Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Solid Tumor Cancers Via Intermediate-Size Patient Population Expanded Access Investigational New Drug (IND)

NCT06980519 is registered in ClinicalTrials.gov with Monopar Therapeutics as lead sponsor.

NCT NCT06980519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06980519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Solid Tumor Cancers Via Intermediate-Size Patient Population Expanded Access Investigational New Drug (IND)
Lead sponsor
Monopar Therapeutics
Phase
Expanded access
Overall status
Temporarily not available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, oncology, solid tumor, solid tumor cancer, upar-positive solid tumor, urokinase plasminogen activator receptor-positive solid tumor